This archive contains links to the full-text of all issues of Clin Mol Hepatol.
![]() |
First decision
09 Days
Publication after acceptance
07 Days
*Last 12 months
Viewed By 4788 |
Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma |
Viewed By 4753 |
Hepatitis B core-related antigen: A novel and promising surrogate biomarker to guide anti-hepatitis B virus therapy |
Viewed By 3767 |
MAFLD: How is it different from NAFLD? |
Viewed By 2613 |
Management of refractory ascites |
Viewed By 2455 |
Global incidence and prevalence of nonalcoholic fatty liver disease |
Cited By 131 |
KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease |
Cited By 78 |
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma |
Cited By 60 |
From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple? |
Cited By 55 |
Obesity and the risk of primary liver cancer: A systematic review and meta-analysis |
Cited By 54 |
Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma |